These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5369674)

  • 21. The antigenic stability of 3 AKR leukemias on isotransplantation and the serologic detection of thymus-derived leukemia cells.
    Reif AE; Allen JM
    Cancer Res; 1966 Jan; 26(1):123-30. PubMed ID: 5901736
    [No Abstract]   [Full Text] [Related]  

  • 22. Distribution and lysis of weakly and strongly immunogenic malignant lymphoid cells in normal and immune mice: effects of prior exposure to heat or X-irradiation.
    Nawrocki JF; Look AT; Selwa JF; Haggis JR; Murphy WH
    J Natl Cancer Inst; 1984 May; 72(5):1085-94. PubMed ID: 6585585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
    Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
    Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Residual cancer.
    Woodruff M
    Harvey Lect; 1971-1972; 66():161-76. PubMed ID: 4949244
    [No Abstract]   [Full Text] [Related]  

  • 25. Induction of graft-versus-leukemia (GVL) effect without graft-versus-host disease (GVHD) by pretransplant donor treatment with immunomodulators.
    Morecki S; Yacovlev E; Gelfand Y; Shabat Y; Slavin S
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):406-15. PubMed ID: 19285627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adoptive therapy of established syngeneic leukemia by cells primarily sensitized in vitro.
    Cheever MA; Greenberg PD; Fefer A
    Cancer Res; 1981 Jul; 41(7):2658-63. PubMed ID: 7018668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A quantitative spleen colony assay method for tumor cells induced by Friend leukemia virus infection in mice.
    Thomson S; Axelrad AA
    Cancer Res; 1968 Oct; 28(10):2104-14. PubMed ID: 5696939
    [No Abstract]   [Full Text] [Related]  

  • 28. Significance of the co-existance of Friend virus in "Friend tumour".
    Kobayashi H; Kodama T; Itoh T
    Nature; 1966 Nov; 212(5065):939-40. PubMed ID: 6003736
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
    Stackpole CW; Demsey A
    Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in mouse 7S gamma-globulin resulting from immunization with transplantable tumours.
    Tee DE; Watkins J; Wang M; Gammack DB; Raper JH
    Immunology; 1965 Jul; 9(1):85-92. PubMed ID: 5838980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Malignancy of Friend erythroleukemic cells in DBA/2 mice correlated with their level of fibronectin sensitivity].
    Benedetto A; Amici C; Djaczenko W; Zaniratti S; Buttò S; Elia G
    Ann Ist Super Sanita; 1982; 18(3):447-51. PubMed ID: 6964823
    [No Abstract]   [Full Text] [Related]  

  • 32. Stimulation of Rauscher virus induced leukemogenesis in mice by complete Freund's adjuvant.
    Ter-Grigorov VS; Irlin IS; Moskovkina OIa; Bergol'ts VM
    Vopr Onkol; 1971; 17(2):54-9. PubMed ID: 5567709
    [No Abstract]   [Full Text] [Related]  

  • 33. Stimulation of porcine splenic cultures by a radiation-induced lymphoid leukemia filtrate: a preliminary report.
    Howard EB; Jannke CC; Clarke WJ
    Am J Vet Res; 1969 Mar; 30(3):423-8. PubMed ID: 5250292
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased susceptibility to tumor cell immunosuppressive effect in tumor-bearing mice.
    Ting CC; Rodrigues D
    J Natl Cancer Inst; 1980 Jul; 65(1):205-9. PubMed ID: 6967124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Responses to donor lymphocyte infusion for acute lymphoblastic leukemia may be determined by both qualitative and quantitative limitations of antileukemic T-cell responses as observed in an animal model for human leukemia.
    Nijmeijer BA; van Schie ML; Verzaal P; Willemze R; Falkenburg JH
    Exp Hematol; 2005 Oct; 33(10):1172-81. PubMed ID: 16219539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase of L5178Y lymphoma growth by means of placental antigen immunization.
    Bravo-Cuéllar A; Gomez-Estrada H; Ramos-Damián M
    Arch Invest Med (Mex); 1982; 13(3):191-4 passim. PubMed ID: 7125799
    [No Abstract]   [Full Text] [Related]  

  • 37. Control of neoplasia by immunological means: an assessment of a new approach.
    Plescia OJ; Braun W
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1970; 63(1):7-18. PubMed ID: 5506659
    [No Abstract]   [Full Text] [Related]  

  • 38. Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype.
    Hanyecz A; Berlo SE; Szántó S; Broeren CP; Mikecz K; Glant TT
    Arthritis Rheum; 2004 May; 50(5):1665-76. PubMed ID: 15146438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative effectiveness of methods for immunizing BALB/cwm mice to transplantable myelomonocytic leukemia.
    Urnovitz HB; Murphy WH
    Leuk Res; 1979; 3(5):329-39. PubMed ID: 293457
    [No Abstract]   [Full Text] [Related]  

  • 40. In vivo characterization of immunogenicity of a mitoxantrone-resistant murine P388 leukemia.
    Fichtner I; Reipert B; Becker M; Lemm M
    In Vivo; 1993; 7(1):73-9. PubMed ID: 8504210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.